Healthcare entity
All 1 tracked stories fall under one category: regulation. GNTbm is most often covered alongside GNTbm-38, which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 5.8. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: Mar 5, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. GNTbm is most often covered alongside GNTbm-38, which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 5.8. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window. GNTbm appears in 1 tracked Healthcare story from March 5, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GNTbm. Shared-story counts are live from our verified record — not editorial picks.
Data Readout
Expected preliminary safety results from the Phase I cohort.
Phase I Commencement
Anticipated start of patient recruitment for safety and dosage studies.
FDA IND Approval
The U.S. FDA approves the application to begin human clinical trials.
Preclinical Development
GNTbm completes laboratory and animal testing for GNTbm-38.
The U.S. FDA has granted Investigational New Drug (IND) approval to GNTbm for its self-developed anti-cancer candidate, GNTbm-38. This milestone allows the company to initiate Phase I clinical trials in the United States, marking its transition into a clinical-stage biopharmaceutical entity.
Source: thailand-business-news.com · manilatimes.net
GNTbm is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
